Be part of our diabetes expert community!

Join EASD to help advance excellence in diabetes care through cutting-edge research, collaboration and education.

Connect with thousands of professionals worldwide, grow your network, and shape the future of diabetes treatment and innovation. 

Recent EASD News
22nd Robert Turner Course

Clinical Research Training Course

This course offers young researchers the opportunity to be trained on clinical research design and analysis in the field of diabetes. Apply by 5 January 2026 to secure your place.

Apply Now

Diabetes Technology School

This course explores current and emerging diabetes technologies in depth. Enhance your expertise in diabetes technology and explore the latest innovations in clinical practice. Apply by 5 January 2026.

General Assembly

Approval of Minutes

Thank you to all EASD members who took part in the electronic vote through Civica Election Services. With your support the minutes of the EASD General Assembly 2025 have been approved.

Statement of Regret

Human Insulin Supply in Europe

EASD expresses deep regret and concern following Novo Nordisk’s decision to discontinue several widely used human insulin products across Europe, with full discontinuation expected by the end of 2026.

Funding European Diabetes Research

Our foundation encourages and supports groundbreaking diabetes research and promotes the next generation of leading scientists

The following grant or fellowship programmes are currently open for applications:

EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe

Supporting all fields of European diabetes research, including both basic and clinical research.

Learn more

EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme

Encouraging young researchers in Europe to develop innovative research activities in the field of diabetes.

Learn more

EFSD/Novo Nordisk Foundation Future Leaders Award Programme

Supporting early- to mid-career diabetes researchers in Europe to help them transition into independent, tenured academic roles.

Learn more

EASD e-learning

New on EASD e-Learning

Introducing Metabologia

Editor-in-Chief Dr Jennifer Sargent introduces EASD's brand-new journal for the metabolism community.

Dementia risk in T1D: Strongest link with vascular subtype

As people with T1D live longer, age-related conditions such as dementia are becoming increasingly important.

Evolving role of GLP-1 RAs in diabetes and PAD

A new tool for an often overlooked but common complication?

Stem cell-derived beta cell for transplantation

Conventional islet transplants have an important constraint: They are limited.

Podcasts

Tune in to Diabetes Insights

Population Level Screening to Detect Early Stage Type 1 Diabetes

In this episode, leading experts Prof. Anette Ziegler (Helmholtz Munich), Prof. Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-O’Neill (Breakthrough T1D) join EASD TV to discuss the emerging global consensus on screening for early-stage type 1 diabetes.

Results from the SOUL Trial: The Cardiologists' Perspective

In this weeks episode, EASD TV continues its deep dive into major clinical trials with the cardiologist’s perspective. Cardiologist Dr. Matthew Cavender (University of North Carolina) joins Vivienne Parry to unpack the SOUL trial further.

Results from the SOUL Trial: The Diabetologists' Perspective

In this episode, Dr Rodica Busui explains the trial’s major outcomes, including a 14% reduction in major adverse cardiovascular events -matching results previously observed with injectable GLP-1 formulations.

ATTAIN-1 - Investigating Orforglipron for Obesity Management

In this episode, Dr. Sean Wharton (University of Toronto and Wharton Medical Clinic, Canada) and Dr. Nasreen Alfaris (King Fahad Medical City, Riyadh, Saudi Arabia) join host Vivienne Parry to discuss the groundbreaking ATTAIN trial, presented at the EASD 2025 Annual Meeting in Vienna.

Submit to our Journals

Publish your research in Diabetologia and Metabologia

EASD has two journals, Diabetologia, which publishes articles on all aspects of diabetes, from basic science through translational work to clinical research, and the newly launched Metabologia, an open access journal for research across the fields of diabetes, obesity, metabolism and related disorders. Both offer a platform for original studies, clinical trials, reviews, and interdisciplinary work that inform scientific understanding and clinical practice.

Learn more